Recruiting EARLY_PHASE1 INTERVENTIONAL 1-arm
NCT07254091
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer
Sponsor: Northwell Health
Conditions
Pancreatic Cancer
Interventions
Device Arm with Therapeutic Agents
Updated 2 times since 2025 Last updated: Mar 4, 2026 Started: Jan 30, 2026 Primary completion: Jan 30, 2027 Completion: Jan 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A EARLY_PHASE1 clinical study on Pancreatic Cancer, this trial is actively recruiting participants. The trial is conducted by Northwell Health and has accumulated 2 data snapshots since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
2 versions recorded-
Mar 2026 — Present [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Dec 2025 — Mar 2026 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Northwell Health
Data source: Northwell Health
For direct contact, visit the study record on ClinicalTrials.gov .